当前位置:首页>产品中心>单抗/多抗>Anti-Human KRAS Recombinant Nanobody (SBT-102)|抗人KRAS纳米抗体(靶标:人KRAS原癌基因)

Anti-Human KRAS Recombinant Nanobody (SBT-102)|抗人KRAS纳米抗体(靶标:人KRAS原癌基因)

  • 货号:RB9THF904033
  • 价格:面议
  • 点击:441

产品介绍

产品参数

形态Liquid
宿主种属Alpaca
克隆性Monoclonal
抗体亚型VHH-His
纯度>95% as determined by SDS-PAGE.
纯化方式Purified by Nickel column.
内毒素水平Please contact with the lab for this information.
应用ELISA
种属反应性Human
靶标EC:3.6.5.2, GTPase KRas, GTPase KRas, N-terminally processed, K-Ras 2, KRAS, KRAS2, Ki-Ras, RASK2, c-K-ras, c-Ki-ras
储存缓冲液0.01M PBS pH 7.4
稳定性和储存Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
产品使用说明ELISA: 1:2000-1:20000
登录号P01116
背景信息

GTPase KRas is a ~21 kDa protein. Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. Plays an important role in the regulation of cell proliferation. Activates MAPK1/MAPK3 resulting in phosphorylation and ultimately degradation of GJA1. Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner.

1. Gremer, L. et al. (2011) Human mutation 32, 33-43. PMID: 20949621
2. Bernal Astrain, G. et al. (2025) Nature communications 16, 647. PMID: 39809765
3. Yang, MH. et al. (2012) Proceedings of the National Academy of Sciences of the United States of America 109, 10843-8. PMID: 22711838
4. Zimmermann, G. et al. (2013) Nature 497, 638-42. PMID: 23698361
5. Serra, RW. et al. (2014) eLife 3, e02313. PMID: 24623306
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Anti-Sarilumab Neutralizing Recombinant Antibody |抗萨瑞鲁单抗中和重组抗体(靶标:萨瑞鲁单抗中和抗体) 390
Anti-Sarilumab Neutralizing Recombinant Antibody |抗萨瑞鲁单抗中和重组抗体(靶标:萨瑞鲁单抗中和抗体) 350
Anti-Sarilumab Neutralizing Recombinant Antibody |抗萨瑞鲁单抗中和重组抗体(靶标:萨瑞鲁单抗中和抗体) 340
Anti-Sarilumab Neutralizing Recombinant Antibody |抗萨瑞鲁单抗中和重组抗体(靶标:萨瑞鲁单抗中和抗体) 359
Anti-Durvalumab Non-Neutralizing Recombinant Antibody |程度伐利尤单抗非中和重组抗体(靶标:度伐利尤单抗非中和抗体) 631
Anti-Durvalumab Non-Neutralizing Recombinant Antibody |抗度伐利尤单抗非中和重组抗体(靶标:度伐利尤单抗非中和抗体) 602
Anti-Durvalumab Neutralizing Recombinant Antibody |抗度伐利尤单抗中和重组抗体(靶标:度伐利尤单抗中和抗体) 396
Anti-Durvalumab Neutralizing Recombinant Antibody |抗度伐利尤单抗中和重组抗体(靶标:度伐利尤单抗中和抗体) 448
Anti-Durvalumab Neutralizing Recombinant Antibody |抗度伐利尤单抗中和重组抗体(靶标:度伐利尤单抗中和抗体) 387
Anti-Durvalumab Neutralizing Recombinant Antibody |抗度伐利尤单抗中和重组抗体(靶标:度伐利尤单抗中和抗体) 379
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody |抗阿替利珠单抗非中和重组抗体(靶标:阿替利珠单抗非中和抗体) 435
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody |抗阿替利珠单抗非中和重组抗体(靶标:阿替利珠单抗非中和抗体) 397
Anti-Atezolizumab Neutralizing Recombinant Antibody |抗阿替利珠单抗中和重组抗体(靶标:阿替利珠单抗中和抗体) 388
Anti-Atezolizumab Neutralizing Recombinant Antibody |抗阿替利珠单抗中和重组抗体(靶标:阿替利珠单抗中和抗体) 434
Anti-Panitumumab Non-Neutralizing Recombinant Antibody |抗帕尼单抗非中和重组抗体(靶标:帕尼单抗非中和抗体) 572
Anti-Panitumumab Non-Neutralizing Recombinant Antibody |抗帕尼单抗非中和重组抗体(靶标:帕尼单抗非中和抗体) 381
Anti-Panitumumab Non-Neutralizing Recombinant Antibody |抗帕尼单抗非中和重组抗体(靶标:帕尼单抗非中和抗体) 334
Anti-Panitumumab Neutralizing Recombinant Antibody |抗帕尼单抗中和重组抗体(靶标:帕尼单抗中和抗体) 311
Anti-Panitumumab Neutralizing Recombinant Antibody |抗帕尼单抗中和重组抗体(靶标:帕尼单抗中和抗体) 296
Anti-Panitumumab Neutralizing Recombinant Antibody |抗帕尼单抗中和重组抗体(靶标:帕尼单抗中和抗体) 306
总计 33037 个记录,共 1652 页,当前第 1647 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00